PLAU and non-small cell lung carcinoma: Staurosporine, a potent PKC inhibitor, controls cell adhesion, mobility, and invasion of A549 cells [10]; IL1-beta induces the expression of urokinase plasminogen activator (uPA) via PKCα, which leads to the migration of A549 NSCLC cells [11].